Owen, William R., Neely, W.B., AND Owens, J.D.: The effect of sodium dextrothyroxine on serum cholesterol in man. J. A. M. A., 174: 1118, 1960 .
2.
Starr, Roen P. , Freibrun, J.L., AND Schleissner , L.A.: Reduction of serum cholesterol by sodium dextro-thyroxine. A. M. A. Arch. Int. Med., 105: 830, 1960.
3.
Dawber, T.R. , Moore, F.E., AND Mann, G.V.: II. Coronary heart disease in the Framingham study. Am. J. Pub. Health , 47: 4, 1947.
4.
Melby, J.C., St. Cyr., Marlys, AND Dale, S.L.: Reduction of adrenal-sterol production by an inhibitor of cholesterol biosynthesis . New England J. Med., 264: 583, 1961 .
5.
Achor, R.W.P. , Winkflmann, R.K., AND Perry, H.O.: Cutaneous side effects from use of triparanol (MER/29): preliminary data on ichthyosis and loss of hair. Proc. Staff Meet. Mayo Clin., 36: 217, 1961.
6.
Hoobler, S., Colwell, C., AND Beierwal-Tes, W.H. : Cholesterol disappearance in rodents. Symposium on sodium d-thyroxine, Chicago, 1959.
7.
Owens, J.C., Neely, W.B., AND Owen, W.R.: Potentiation of anticoagulant effect of warfarin by dextro-thyroxine . New England J. Med., in press.
8.
Turner, K.B. : Studies on the prevention of cholesterol atherosclerosis in rabbits. J. Exper. Med., 58: 115, 1933.
9.
Menne, F.R., Beeman, J.A.P., AND Libbey, D.H.: Cholesterol induced atherosclerosis in rabbits with variations due to altered status of thyroid. A. M. A. Arch. Path., 24: 612, 1937.
